18 06, 2018

OREF Award To Improve Total Joint Replacement Outcomes

2019-04-19T20:37:24+00:00June 18th, 2018|

The AAD group and Dr. Urish are enormously appreciative of the Orthopaedic Research and Education Foundation for their generous support in improving orthopaedic research. We are excited to have been given the Galante Total Joint Replacment Award. This three year grant will support our laboratory to improve and extend implant survival by investigating new methods to treat infection.

5 06, 2018

New Antibiotics To Prevent And Fight Surgical Infection

2019-04-19T20:35:37+00:00June 5th, 2018|

Peptilogics Received Qualified Infectious Disease Product Designation from the FDA for Lead Compound PLG0206 as a Treatment for Prosthetic Joint Infection. We are very proud of our involvment with Peptilogics to help introduce a new antimicrobial compound, PLG0206, to prevent and fight surgical infection. More information can be found here.

27 04, 2018

Minimizing Pain After Joint Replacement

2019-04-19T20:32:24+00:00April 27th, 2018|

Dr. Urish lead a clinical study at the Magee Bone and Joint Center on new methods to minimize post operative pain after total knee and hip replacement. Details can be read here.

17 04, 2018

World Arthroplasty Congress, Rome 2018

2019-04-19T20:28:29+00:00April 17th, 2018|

Dr. Urish was invited to speak about current technologies with total hip arthroplasty to the World Arthroplasty Congress held in Rome in April. You can watch a version of the talk here.

26 03, 2018

WLBU2: A New Class Of Antibiotics

2019-04-19T20:25:30+00:00March 26th, 2018|

Dr. Urish's group report on a new class of antimicrobial agents to fight and prevent surgical infection. 

Go to Top